Hillary Clinton Statement on EpiPen Pricing

Hillary Clinton called out drug maker Mylan for the increase in the price of its EpiPen product. An EpiPen is used to prevent anaphylactic shock by those with serious allergy attacks. The active drug in the product, the hormone epinephrine, costs less than $1 for the amount in a single dose. Yet, researchers note that the price of the EpiPen has increased 400% over the past few years with one EpiPen costing $57 in 2007 and a two pack of EpiPens costing $600 today. Clinton is not alone in asking Mylan for explanation. Senators Susan Collins of Maine and Claire McCaskill of Missouri have also sent letters to the manufacture. Late last year, Clinton proposed updates to prescription drug regulations that will prevent drug makers from overcharging for medications. A copy of Clinton’s statement is below.

“Millions of Americans with severe allergies rely on their EpiPens.  When an allergic reaction leads to anaphylactic shock, a shot of epinephrine can literally be the difference between life and death.  But now, just as parents are about to send kids with severe food and insect allergies back to school, the EpiPen’s manufacturer is hiking its price to an all-time high.

Over the last several years, Mylan Pharmaceuticals has increased the price of EpiPens by more than 400%.  They’re now charging up to $600 for a two-EpiPen set that must be replaced every 12-18 months. This both increases out-of-pocket costs for families and first responders, and contributes to higher premiums for all Americans and their employers.

That’s outrageous — and it’s just the latest troubling example of a company taking advantage of its consumers. I believe that our pharmaceutical and biotech industries can be an incredible source of American innovation, giving us revolutionary treatments for debilitating diseases.  But it’s wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them. 

That’s why I’ve put forward a plan to address exorbitant drug price hikes like these.  As part of my plan, I’ve made clear that pharmaceutical manufacturers should be required to explain significant price increases, and prove that any additional costs are linked to additional patient benefits and better value.  Since there is no apparent justification in this case, I am calling on Mylan to immediately reduce the price of EpiPens.

In addition, when it comes to treatments like delivering epinephrine that have been available for decades, my plan encourages the production of alternative products.  That’s how we can harness the power of competition to keep drug prices at a level that all Americans can afford.”

For all the latest, follow our Scheduled Events page and follow Clinton on Twitter, Facebook, YouTube, and Instagram. Also, be sure to subscribe to the campaign’s official Podcast, With Her.

News Source: The Verge

Hillary Clinton Proposes Rapid Response Fund to Fight Pandemics

Hillary Clinton proposed a new Public Health Rapid Response Fund to deal with pandemics such as Zika virus. Clinton has urged Congress to pass federal funding to assist areas infested with Zika carrying mosquitoes, but Congress has failed to do so. Clinton said that the fund would be available to assist “the CDC, HHS, FEMA, state and local public health departments, hospital systems, and other federal agencies” respond to any public health crisis. A copy of the release from Hillary for America is below.

“The United States faces new threats to public health, from pandemic diseases like those caused by the Ebola and the Zika viruses, to the risk of biological weapons and bioterrorism, to long-term challenges like more extreme weather and expanding ranges for Lyme disease and water-borne illnesses as a result of climate change. And in a global economy, diseases like SARS, MERS, and avian influenza cannot be contained in their countries of origin.

“But despite these threats, we are not investing in public health preparedness and emergency response the way we should to keep our families and communities safe. A 2015 study found that spending on public health had fallen more than 9 percent since 2008. And uncertain long-term budgets leave our public health agencies dependent on emergency appropriations—meaning that when Congress fails to step up, communities are left without the resources they need, vaccines languish in development, and more people get sick.

That is why as President, I will create a Public Health Rapid Response Fund, with consistent, year-to-year budgets, to better enable the CDC, HHS, FEMA, state and local public health departments, hospital systems, and other federal agencies to quickly and aggressively respond to major public health crises and pandemics. I will also ensure that our government has strong leadership and is organized to better support and work with people on the ground facing public health challenges. Doctors and public health experts have been warning for months that the Zika virus was likely to reach the continental United States, but Congress has failed to pass the President’s emergency funding request. As a result, the Zika virus has gained a foothold in Miami, and 196 people have already been infected in the city—infections that may have been preventable. 

In addition, we need to do more to boost our preparedness for biological threats and bioweapons; to support research for new diagnostic tests, therapeutic treatments, and vaccines for emerging diseases; to build capacity in public health departments; to train the next cadre of public health professionals and ensure that public health and environmental health practices are standard to the educations of medical students; and to provide resources for states and local governments to plan for complex, multi-faceted public health threats, like the impacts of climate change, and build more resilient communities.”

For all the latest, follow our Scheduled Events page and follow Clinton on Twitter, Facebook, YouTube, and Instagram. Also, be sure to subscribe to the campaign’s official Podcast, With Her.

News Source: Politico